Title: Ozempic and Wegovy protect the heart, even without weight loss

Summary: Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who qualifies for the drug.

Link: https://www.sciencedaily.com/releases/2025/10/251030075125.htm